Publikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (12)

2025

  1. Dehydrothyrsiferol Against Cutaneous Leishmaniasis: Treatment Outcome in a Murine Model

    Marine Drugs, Vol. 23, Núm. 1

  2. Infectious disease risk after the October 2024 flash flood in Valencia, Spain: Disaster evolution, strategic scenario analysis, and extrapolative baseline for a One Health assessment

    One Health, Vol. 21

2024

  1. E-Cyanoacrylamides and 5-Imino Pyrrolones against Trypanosoma cruzi: Activity and Induced Mechanisms of Cell Death

    Tropical Medicine and Infectious Disease, Vol. 9, Núm. 9

  2. In Vivo Evaluation of Sepigel-Based Meglumine Antimoniate and Amphotericin B for Cutaneous Leishmaniasis Treatment

    Pathogens, Vol. 13, Núm. 8

2023

  1. Meroterpenoids from Gongolaria abies-marina against Kinetoplastids: In Vitro Activity and Programmed Cell Death Study

    Pharmaceuticals, Vol. 16, Núm. 4

  2. Withaferin A-silyl ether analogs as potential anti-kinetoplastid agents targeting the programmed cell death

    Biomedicine and Pharmacotherapy, Vol. 157

2022

  1. In vitro activity and cell death mechanism induced by acrylonitrile derivatives against Leishmania amazonensis

    Bioorganic Chemistry, Vol. 124

  2. Ozone treatment effectively eliminates SARSCoV-2 from infected face masks

    PLoS ONE, Vol. 17, Núm. 7 July

2021

  1. Acrylonitrile derivatives against trypanosoma cruzi: In vitro activity and programmed cell death study

    Pharmaceuticals, Vol. 14, Núm. 6

  2. Antikinetoplastid activity of sesquiterpenes isolated from the zoanthid palythoa aff. Clavata

    Pharmaceuticals, Vol. 14, Núm. 11

  3. Discovery of new chemical tools against leishmania amazonensis via the mmv pathogen box

    Pharmaceuticals, Vol. 14, Núm. 12

2020

  1. New phenalenone analogues with improved activity against Leishmania species

    Biomedicine and Pharmacotherapy, Vol. 132